Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
30 participants
INTERVENTIONAL
2020-08-07
2020-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Ultra-wide-field imaging systems allowed for visualization of peripheral perfusion abnormalities in myopic eyes that were previously unknown.
In Austria, there are two different wide-field imaging systems available. The first device on the market was the Optos (Optos PLC, Dunfermline, UK) and several years later the Clarus 500 (Carl Zeiss, Meditec AG, Jena, Germany) was introduced.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
COmparison of Clarus and Optos Ultrawide Field Imaging Systems for Inherited Retinal Disease
NCT06380075
Objective Assessment of Macular Function at Retinal and Cortical Levels
NCT03517241
Assessment of Retinal Fundus Imaging Camera
NCT06173232
Non-invasive Optical Angiography in Age-related Macular Degeneration
NCT02521142
Comparison of Retinal Oxygenation and Retinal Vessel Diameters in Healthy Subjects and Patients With Diabetic Retinopathy or Retinal Vein Occlusion Between DVA and Oxymap
NCT02521116
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Aim: To compare two CE-marked imaging systems concerning the extent of retinal periphery area viewing.
We would like to perform a prospective observational study that would include patients divided into three groups: myopic patients, hyperopic and emmetropic patients.
Fundus photography will be performed using two ultra-wide-field imaging systems (Optos, Daytona, Optos PLC, Dunfermline, UK and Clarus, 500 Carl Zeiss, Meditec AG, Jena, Germany), performed by the same investigator.
All images with sufficient quality will be exported and saved to hard-disk. The difference in periphery view will be investigated as follows: two retinal photos for each patient will be imported into Photoshop CS6 image-editing system (Adobe, version 13.0.0) where the anatomical landmarks will be matched for each image and the borders will be compared to see if there are differences in retinal periphery area viewing between the two devices.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Extent of retinal periphery area viewing
For the 30 patients fundus photography will be performed using two ultra-wide-field imaging systems.
extent of retinal area viewing Optos, Daytona, Optos PLC, Dunfermline, UK
Comparison of the extent of retinal periphery view between two wide field imaging devices.
extent of retinal area viewing Clarus, 500 Carl Zeiss, Meditec AG, Jena, Germany
Comparison of the extent of retinal periphery view between two wide field imaging devices.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
extent of retinal area viewing Optos, Daytona, Optos PLC, Dunfermline, UK
Comparison of the extent of retinal periphery view between two wide field imaging devices.
extent of retinal area viewing Clarus, 500 Carl Zeiss, Meditec AG, Jena, Germany
Comparison of the extent of retinal periphery view between two wide field imaging devices.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Myopic (at least -5.00Dsph), hyperopic (over +3.00Dsph) and emmetropic patients
* Written informed consent prior to any study specific action.
Exclusion Criteria
* Fixation problems, nystagmus
* pregnancy- for women in reproductive age a pregnancy test will be performed.
21 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Prim. Prof. Dr. Oliver Findl, MBA
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prim. Prof. Dr. Oliver Findl, MBA
Head of Ophthalmology Department, principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Oliver Findl, Prof.
Role: PRINCIPAL_INVESTIGATOR
VIROS, Hanusch Hospital Vienna
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Vienna Institute for Research in Ocular Surgery (VIROS), Hanusch Hospital Vienna
Vienna, , Austria
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UWF
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.